By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


European Medicines Agency (EMA) 

7 Westferry Circus
Canary Wharf
London    E14 4HB  United Kingdom
Phone: 44-0-20-7523-7600 Fax: n/a



Company News
AB Science (AB.PA) Announces The Filing Of Masitinib In The Treatment Of Amyotrophic Lateral Sclerosis (ALS) To The EMA 9/30/2016 7:26:55 AM
Advanced Accelerator Applications Release: EMA Prematurely Announced Opinion On SomaKit TOC Kit Application 9/23/2016 8:04:57 AM
Ireland Makes Its Case to Be New Home for the EMA Following Brexit 9/23/2016 6:19:32 AM
bluebird bio (BLUE) Release: Lentiglobin Investigational Gene Therapy For Transfusion-Dependent Beta-Thalassemia Accepted Into EMA’s PRIME Program 9/21/2016 11:37:31 AM
EMA Validates Bristol-Myers Squibb (BMY)’s Type II Variation Application For Opdivo (nivolumab) In Advanced Form Of Bladder Cancer 9/20/2016 11:47:26 AM
Advanced Accelerator Applications Announces Revised EMA Review Timeline For Lutathera 9/20/2016 7:59:13 AM
UCB, Inc. (UCBJF.PK) Receives EMA Regulatory Approval For Pre-filled Pen With Core Bespak Technology 9/19/2016 11:43:04 AM
Advanced Accelerator Applications Announces Positive EMA Opinion On Application For Somakit TOC Kit For Radiopharmaceutical Preparation Of Gallium (Ga 68) Edotreotide For Gastroenteropancreatic Neuroendocrine Tumor Detection 9/16/2016 7:58:25 AM
Repros Therapeutics (RPRX) Announces Submission Of MAA To The EMA For Enclomiphene In The Treatment Of Secondary Hypogonadism 9/13/2016 10:05:38 AM
Janssen-Cilag AG Submits Marketing Authorisation Application For Darunavir-Based Single Tablet Regimen For Treatment Of HIV-1 To EMA 9/12/2016 11:33:03 AM